Laurion Capital Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Laurion Capital Management’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,013,300	Closed	-$351K	–	720
2023 Q1	$351K	Hold	2,013,300	–	–	﹤0.01%	361
2022 Q4	$800K	Hold	2,013,300	–	–	﹤0.01%	341
2022 Q3	$1.57M	Buy	2,013,300 +1,700,000	+543%	+$3.57M	0.01%	341
2022 Q2	$902K	Buy	+313,300	New	+$1.1M	0.01%	291

Laurion Capital Management's CDAK Position: Q2 2023 in Review

Laurion Capital Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 2,013,300 shares — an estimated $351K sold.

Laurion Capital Management first reported a position in CDAK in Q2 2022 and held it in 4 quarters. The position peaked at $1.57M in Q3 2022. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Laurion Capital Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Laurion Capital Management sold 2,013,300 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $351K.
Laurion Capital Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Laurion Capital Management's Codiak BioSciences, Inc. Common Stock position peaked at $1.57M in Q3 2022.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.